Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: The study of patients intolerant of converting enzyme inhibitors registry

American Journal of Medicine

Volumn 109, Issue 6, 2000, Pages 489-492

  Shah, Monica R ^a   Granger, Christopher B ^a   Bart, Bradley A ^a   McMurray, John J V ^a   Petrie, Mark C ^b   Michelson, Eric L ^c   Tudor, Gail E ^a   Swedberg, Karl ^d   Stevenson, Lynne W ^e   Califf, Robert M ^a   Pfeffer, Marc A ^e  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; INOTROPIC AGENT; NITRATE; WARFARIN;

ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; COUGHING; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; PRURITUS; RASH; REGISTER; SEX DIFFERENCE; TASTE DISORDER;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; DIURETICS; FEMALE; HEART FAILURE, CONGESTIVE; HUMAN; MALE; MIDDLE AGE; PRESCRIPTIONS, DRUG; REGISTRIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034667958     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00529-5     Document Type: Article

References (18)

1. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults
2. Where are all the women with heart failure?
3. Contemporary management of patients with left ventricular systolic dysfunction: Results from the Study of Patients Intolerant of Converting Enzyme inhibitors (SPICE) Registry
4. A randomized trial of candesartan cilexetil in patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
5. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure
6. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy
7. Heart failure between 1986 and 1994; temporal trends in drug-prescribing practices: Hospital readmissions, and survival at an academic medical center
8. Prediction of creatinine clearance from serum creatinine
9. Tolerability of enalapril initiation by patients with left ventricular dysfunction: Results of the medication challenge phase of the Studies of Left Ventricular Dysfunction
10. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
11. Studies of Left Ventricular Dysfunction (SOLVD) Registry: Rationale, design, methods and description of baseline characteristics
12. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD)
13. The epidemiology of heart failure: The Framingham Study
14. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
15. Effects of enalapril on mortality in severe congestive heart failure
16. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
17. Clinical trials of diuretic therapy in heart failure: Research directions and clinical considerations